Skip to content
Catalyst

Serenoa repensFinding

Serenoa repens has no detected effect on International Prostate Symptom Score / AUA Symptom Index

no difference foundVery limited evidenceFinding

01 · The sentence it was drawn from

“In a meta-analysis of two high quality long-term trials (n = 582), Serenoa repens therapy was not superior to placebo in reducing LUTS based on the AUA (mean difference (MD) 0.25 points, 95% confidence interval (CI) -0.58 to 1.07).”
Quoted verbatim from Serenoa repens for benign prostatic hyperplasia.
This finding among the 1 finding on its endpoint

Serenoa repens

International Prostate Symptom Score / AUA Symptom Index

no difference found

Effect as reported

0.25mean difference

CI −0.58 to 1.07

Who
n = 582 · Men with lower urinary tract symptoms consistent with benign prostatic hyperplasia; pooled two high quality long-term trials
Dose studied
not reported

Very limited evidencePMID 23235581 · 2013

02 · The study

Study
meta-analysis
Participants
582
Duration
not reported

Evidence, by strength

  • strong
  • moderate
  • limited
  • very limitedthis finding
  • insufficient

03 · The paper

The Cochrane database of systematic reviews
What else it reported2 findings · 0 compounds · 2 endpoints

04 · To cite this finding

This address does not change

https://catalystproject.ai/e/01M6Y19RX5ER0T8RGCBDBJDWRF